Combined inhibition of DNA Polymerase Theta and ATR targets MYBL2-high triple-negative breast cancer stem cells. (jci.org)

Authors: Bayley R … Garcia P Journal: Journal of Clinical Investigation Published: 2026-10-13 DOI: https://doi.org/10.1172/JCI202898